Metabolic Disease
Research activity is centered on type 2 diabetes and obesity, with attention to glucose metabolism and overweight populations.
- Type 2 diabetes
- Obesity
- Overweight populations
The sponsor’s clinical work in this area is focused on metabolic regulation and disease-related changes in energy balance.
Postprandial Glucose Control
The funded research examines glucose handling after a mixed meal tolerance test, reflecting interest in how metabolic responses change in everyday feeding conditions.
- Mixed meal tolerance test
- Postprandial glucose response
- Metabolic regulation
This area links closely to the management of glycaemic disturbance in people living with obesity and type 2 diabetes.
Endocrine and Cardiometabolic Health
The clinical focus includes cardiometabolic disease features associated with impaired insulin action and excess adiposity.
- Insulin resistance
- Metabolic dysfunction
- Cardiometabolic risk
Research interest extends to the interaction between endocrine control and body-weight-related metabolic outcomes.
Clinical Development in Metabolic Therapeutics
The sponsor is engaged in clinical research around metabolic therapeutics intended for people with type 2 diabetes and obesity.
- Metabolic therapeutics
- Glycaemic control
- Body-weight management
Its trial activity is concentrated in a small number of collaborating research sites within Europe.
